Sunil Datta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sunil Datta has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Bindu Joseph
Institute of Health and Wellbeing, Federation University
4 shared publications - Muhammad Aziz Rahman
Department of Noncommunicable Diseases, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh
4 shared publications - Parul Parul
Institute of Health and Wellbeing, Federation University Australia, Berwick, Australia
3 shared publications - Avinash De Sousa
Department of Psychiatry, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, Maharashtra, India
2 shared publications - Parul
Institute of Health and Wellbeing, Federation University Australia, Berwick, Australia
1 shared publication
Latest Publications
- Open Access
- 2 February 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Attitudes, self-efficacy, and practice of psychiatrists to provide smoking cessation support among people with serious mental illness (SMI)
People with serious mental illness (SMI) are significantly more likely to smoke, leading to higher rates of chronic illness and premature death. Despite th
- 2 February 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Open AccessAttitudes, self-efficacy, and practice of psychiatrists to provide smoking cessation support among people with serious mental illness (SMI)
People with serious mental illness (SMI) are significantly more likely to smoke, leading to higher rates of chronic illness and premature death. Despite th
- Open Access
- 27 February 2025
- Published by Springer Nature in Community Mental Health Journal
- Vol. 61 (7) , 1225-1237
Through the Lens of Psychiatrists: Understanding Smoking Cessation Behaviour Among People with Serious Mental Illness
Smoking among people with Serious Mental Illness (SMI) is a pleading public health concern as the rates are much higher compared to the general population. Although different interventions are available to provide cessation support, there is limited evidence of assessing psychiatrists’ perspectives on smoking cessation among people with SMI. The study aims to explore the perspectives of psychiatrists regarding smoking cessation among people with SMI. The study used a qualitative approach. In-depth interviews were conducted with ten psychiatrists, exploring their opinions about smoking and its cessation among people with SMI. Purposive sampling was employed. Data saturation was achieved when no new information was gathered. The verbatim transcripts were analysed using thematic analyses. A total of 14 subthemes emerged under seven themes, highlighting the perspective of psychiatrists in terms of the utilisation of smoking as a coping mechanism among people with SMI. Findings, such as priority of care, time constraints and patient initiative, emphasised the factors impacting cessation. Psychiatrists expressed that support from peers and family members significantly influences smoking cessation among people with SMI. Furthermore, merely engaging in asking, assessing and advicing components from the World Health Organisation 5As scale implied insufficient usage of the 5As tool while discussing cessation. Psychiatrists recognise the impact of cessation on mental health outcomes, like the utilisation of smoking as a coping mechanism. Their experiences and challenges with cessation highlighted time commitment and priority of care while contemplating cessation. The deepened insight provided by our study findings has been instrumental in shaping the content of tailored interventions related to smoking cessation among people with SMI.
- 27 February 2025
- Published by Springer Nature in Community Mental Health Journal
- Vol. 61 (7) , 1225-1237
Open AccessThrough the Lens of Psychiatrists: Understanding Smoking Cessation Behaviour Among People with Serious Mental Illness
Smoking among people with Serious Mental Illness (SMI) is a pleading public health concern as the rates are much higher compared to the general population. Although different interventions are available to provide cessation support, there is limited evidence of assessing psychiatrists’ perspectives on smoking cessation among people with SMI. The study aims to explore the perspectives of psychiatrists regarding smoking cessation among people with SMI. The study used a qualitative approach. In-depth interviews were conducted with ten psychiatrists, exploring their opinions about smoking and its cessation among people with SMI. Purposive sampling was employed. Data saturation was achieved when no new information was gathered. The verbatim transcripts were analysed using thematic analyses. A total of 14 subthemes emerged under seven themes, highlighting the perspective of psychiatrists in terms of the utilisation of smoking as a coping mechanism among people with SMI. Findings, such as priority of care, time constraints and patient initiative, emphasised the factors impacting cessation. Psychiatrists expressed that support from peers and family members significantly influences smoking cessation among people with SMI. Furthermore, merely engaging in asking, assessing and advicing components from the World Health Organisation 5As scale implied insufficient usage of the 5As tool while discussing cessation. Psychiatrists recognise the impact of cessation on mental health outcomes, like the utilisation of smoking as a coping mechanism. Their experiences and challenges with cessation highlighted time commitment and priority of care while contemplating cessation. The deepened insight provided by our study findings has been instrumental in shaping the content of tailored interventions related to smoking cessation among people with SMI.
- Open Access
- 30 January 2025
- Published by Springer Nature in Psychiatric Quarterly
- Vol. 96 (1) , 213-226
Psychiatrists’ Attitude Towards Smoking Cessation Support (PATSS): Exploring Psychometric Properties of the Measurement Tool
The attitude of psychiatrists plays a crucial role in screening and supporting smoking cessation, especially with people with serious mental illness (SMI). The development of an attitude scale can improve the success of quitting among people with SMI. This study aimed to develop and test the psychometric properties of psychiatrists’ attitudes toward smoking cessation support (PATSS). Based on the literature review, the attitude scale, which comprised 15 items, was developed and tested with 289 psychiatrists. The tool’s psychometric properties were tested by examining item performance, content and construct validity (by exploratory factor analysis (EFA), confirmatory factor analysis (CFA), and reliability. The content validity was demonstrated by content validity ratio (CVR) (0.80) and item content validity index (ICVI) (0.88). Both EFA and CFA identified four factors: Priority and Time Commitment, Recovery Impact and Training, Social Support and Patient Factors, and Coping Mechanisms and Rights. A Cronbach alpha of (0.81) demonstrated high internal consistency. PATSS was found to be a valid and reliable tool to assess the attitude of psychiatrists towards smoking cessation support provided to people with SMI.
- 30 January 2025
- Published by Springer Nature in Psychiatric Quarterly
- Vol. 96 (1) , 213-226
Open AccessPsychiatrists’ Attitude Towards Smoking Cessation Support (PATSS): Exploring Psychometric Properties of the Measurement Tool
The attitude of psychiatrists plays a crucial role in screening and supporting smoking cessation, especially with people with serious mental illness (SMI). The development of an attitude scale can improve the success of quitting among people with SMI. This study aimed to develop and test the psychometric properties of psychiatrists’ attitudes toward smoking cessation support (PATSS). Based on the literature review, the attitude scale, which comprised 15 items, was developed and tested with 289 psychiatrists. The tool’s psychometric properties were tested by examining item performance, content and construct validity (by exploratory factor analysis (EFA), confirmatory factor analysis (CFA), and reliability. The content validity was demonstrated by content validity ratio (CVR) (0.80) and item content validity index (ICVI) (0.88). Both EFA and CFA identified four factors: Priority and Time Commitment, Recovery Impact and Training, Social Support and Patient Factors, and Coping Mechanisms and Rights. A Cronbach alpha of (0.81) demonstrated high internal consistency. PATSS was found to be a valid and reliable tool to assess the attitude of psychiatrists towards smoking cessation support provided to people with SMI.
- Open Access
- 10 August 2024
- Published by Springer Nature in Community Mental Health Journal
- Vol. 61 (1) , 147-157
Correlates of Tobacco Use Among People with Mental Illness Within Asia: A Scoping Review
Tobacco use among people with mental illness is one of the contributing risk factors for premature morbidity and mortality. Two in three people with mental illness are current smokers with deteriorating physical health and quality of life. This review outlines the prevalence and predictors of tobacco use among people with mental illness in Asia. Twenty-five cross-sectional studies were selected from the exhaustive search of databases. Ten countries emerged based on the number of studies conducted within Asia among people diagnosed with mental illness and tobacco use, namely, India (8), China (7), Pakistan (2), Singapore (2), Sri Lanka (01), Japan (01), Jordan (01), Malaysia (01), Korea (01), and Taiwan (01). The prevalence of tobacco use was in the range of 3.6% to 89.4%, with the measure of precision at 95% confidence. The highest and lowest prevalence was reported in China, followed by India. Being male, separated, lower education, unemployed, lack of family support, a psychotic diagnosis, lack of knowledge, motivation, and a coping mechanism were predictors of tobacco use. This review emphasized the extent and predictors of tobacco use among this vulnerable group that need to be reflected while initiating and implementing cessation strategies by healthcare providers.
- 10 August 2024
- Published by Springer Nature in Community Mental Health Journal
- Vol. 61 (1) , 147-157
Open AccessCorrelates of Tobacco Use Among People with Mental Illness Within Asia: A Scoping Review
Tobacco use among people with mental illness is one of the contributing risk factors for premature morbidity and mortality. Two in three people with mental illness are current smokers with deteriorating physical health and quality of life. This review outlines the prevalence and predictors of tobacco use among people with mental illness in Asia. Twenty-five cross-sectional studies were selected from the exhaustive search of databases. Ten countries emerged based on the number of studies conducted within Asia among people diagnosed with mental illness and tobacco use, namely, India (8), China (7), Pakistan (2), Singapore (2), Sri Lanka (01), Japan (01), Jordan (01), Malaysia (01), Korea (01), and Taiwan (01). The prevalence of tobacco use was in the range of 3.6% to 89.4%, with the measure of precision at 95% confidence. The highest and lowest prevalence was reported in China, followed by India. Being male, separated, lower education, unemployed, lack of family support, a psychotic diagnosis, lack of knowledge, motivation, and a coping mechanism were predictors of tobacco use. This review emphasized the extent and predictors of tobacco use among this vulnerable group that need to be reflected while initiating and implementing cessation strategies by healthcare providers.